References
- Hu XL, Feng C, Lin XH, et al. High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth. J Clin Endocrinol Metab 2014;99:2217–24
- Kyrou D, Kolibianakis EM, Fatemi HM, et al. Increased live birth rates with gnrh agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. Hum Reprod Update 2011;17:734–40
- Martins WP, Ferriani RA, Navarro PA, et al. GnRH agonist during luteal phase in women undergoing assisted reproductive techniques: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol 2016;47:144–51
- Oliveira JB, Baruffi R, Petersen CG, et al. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol 2010;8:107
- Van der Linden M, Buckingham K, Farquhar C, et al. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015;7:CD009154
- Pirard C, Donnez J, Loumaye E. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Hum Reprod 2005;20:1798–804
- Tesarik J, Hazout A, Mendoza-Tesarik R, et al. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 2006;21:2572–9
- Davar R, Mojtahedi MF, Miraj S. Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT. Iran J Reprod Med 2015;13:483–8
- Haas J, Lantsberg D, Feldman N, et al. Modifying the luteal phase support in natural cycle frozen-thawed embryo transfer improves cycle outcome. Gynecol Endocrinol 2015;31:891–3
- Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod 2004;19:1176–80
- Fusi FM, Arnoldi M, Bosisio C, et al. Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome. Gynecol Endocrinol 2015;31:693–7
- Simsek E, Bulgan Kilicdag E, Caglar Aytac P, et al. Addition of gonadotropin releasing hormone agonist for luteal phase support in in-vitro fertilization: an analysis of 2739 cycles. J Turk Ger Gynecol Assoc 2015;16:96–101
- Check JH, Choe JK, Cohen R, et al. Effect of taking a one time injection of one mg leuprolide acetate three days after embryo transfer on pregnancy outcome and level of first beta human chorionic gonadotropin (beta-hCG) level. Clin Exp Obstet Gynecol 2015;42:568–70
- Zafardoust S, Jeddi-Tehrani M, Akhondi MM, et al. Effect of administration of single dose GnRH agonist in luteal phase on outcome of ICSI-ET cycles in women with previous history of IVF/ICSI failure: a randomized controlled trial. J Reprod Infertil 2015;16:96–101
- Cahill DJ, Fountain SA, Fox R, et al. Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy. Hum Reprod 1994;9:1243–6
- Papanikolaou EG, Platteau P, Albano C, et al. Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration. Reprod Biomed Online 2005;10:347–9
- Abu-Heija AT, Fleming R, Yates RW, et al. Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: comparisons in patients with normal or elevated luteinizing hormone. Hum Reprod 1995;10:3317–19
- Nam DH, Lee SH, Kim HS, et al. The role of gonadotropin-releasing hormone (GnRH) and its receptor in development of porcine preimplantation embryos derived from in vitro fertilization. Theriogenology 2005;63:190–201
- Iwashita M, Kudo Y, Shinozaki Y, et al. Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women. Endocr J 1993;40:539–44